Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when VSTD files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsCritical incident detected
Fraud / investigation
Time-sensitive event — see the red-flag panel below for the source-quoted detail.
Red Flags Detected
- Delisting (new) — Company received second formal Nasdaq deficiency notice for non-compliance with periodic filing requirements.
- Restatement (new) — Ongoing financial restatement has prevented timely filing of both quarterly and annual reports since October 2025.
Vestand receives second Nasdaq delisting notice amid ongoing financial restatement
Filed April 29, 2026 · Period ending April 23, 2026 · ~1 min read
Key Changes
-
high
Vestand received formal Nasdaq deficiency notice on April 23, 2026 for failing to file 2025 annual report (10-K), marking second delisting warning after missing Q3 2025 quarterly report.
Item 8.01 view on EDGAR → -
high
Company plans to submit compliance plan requesting extension until May 18, 2026 to file delinquent reports, but Nasdaq has full discretion to accept, modify, or reject the request.
Item 8.01 view on EDGAR → -
high
Filing delays stem from ongoing financial restatement disclosed October 31, 2025, indicating errors in previously reported results that require significant accounting corrections.
Item 8.01 view on EDGAR → -
high
Vestand explicitly warns it cannot guarantee regaining compliance with Nasdaq filing requirements or avoiding delisting, acknowledging material uncertainty about meeting any deadline.
Item 8.01 view on EDGAR →
Summary
Vestand disclosed receiving its second Nasdaq deficiency notice in six months, this time for failing to file its 2025 annual report by the required deadline. The company previously missed its Q3 2025 quarterly filing, and both delays stem from an ongoing financial restatement announced last October.
Multiple filing delinquencies significantly increase delisting risk and suggest deeper accounting or operational problems that management has been unable to resolve for over six months. Retail investors should understand that delisting would severely impact stock liquidity and access to capital markets. While Vestand plans to request an extension until May 18, 2026, Nasdaq has complete discretion to reject this plan.
The company's explicit warning that it "cannot give assurance" of regaining compliance is particularly concerning, as management typically avoids such stark language unless the situation is genuinely uncertain. Watch for any announcement from Nasdaq regarding acceptance or rejection of the compliance plan, and monitor whether Vestand files the delinquent reports by mid-May. If the company misses this deadline or Nasdaq rejects the plan, formal delisting proceedings would likely begin, potentially forcing the stock to over-the-counter markets with far less liquidity and institutional support.
Section-by-Section Diff
Event · Item 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule
Item 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
On April 23, 2026, Vestand Inc. (the “Company”) received a staff deficiency notice (the “Notice”) from The Nasdaq Stock Market (“Nasdaq”) indicating that, because Nasdaq has not yet received the Company’s Form 10-K for the period ended December 31, 2025, the Company no longer complies with the Nasdaq Listing Rules for continued listing under Rule 5250(c) (1) (the “Periodic Filing Requirement”).
Vestand received a formal deficiency notice from Nasdaq on April 23, 2026, for failing to file its annual report (Form 10-K) for the year ended December 31, 2025. This non-compliance with Nasdaq Listing Rule 5250(c)(1) puts the company at risk of delisting, though the notice has no immediate effect on the stock's listing status.
Added in current filing · verify on EDGAR →
As reported in a press release dated December 2, 2025, the Company previously received a deficiency notice from Nasdaq for failing to file its Form 10-Q for the quarter ended September 30, 2025. The Company’s failure to file its Form 10-K for the period ended December 31, 2025, is considered an additional delinquency.
This is the second deficiency notice from Nasdaq. The company previously failed to file its Q3 2025 quarterly report (10-Q) and has now also missed its annual report deadline. Multiple delinquencies increase delisting risk and suggest deeper operational or accounting issues.
Added in current filing · verify on EDGAR →
The Company was unable to file its Form 10-Q for the quarter ended September 30, 2025, and its Form 10-K for the year ended December 31, 2025 (the “Delinquent Reports”) within the prescribed time periods due to the Company’s ongoing financial restatement, as disclosed in its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission (the “SEC”) on October 31, 2025.
The root cause of both filing delays is an ongoing financial restatement that was previously disclosed in an October 31, 2025, 8-K filing. Financial restatements typically indicate errors in previously reported results and require significant accounting work to correct, which is preventing timely SEC filings.
Added in current filing · verify on EDGAR →
The Company is working diligently to complete the filing of the Delinquent Reports, the filing of which is expected to address the delinquency filing concern by Nasdaq; however, no assurance can be given that the Company will be able to regain compliance with the Periodic Filing Requirement.
Despite stating it is working to file the delinquent reports, Vestand explicitly warns it cannot guarantee it will regain compliance with Nasdaq's filing requirements. This suggests significant uncertainty about the company's ability to complete the restatement and file required reports by any deadline.
Event · Item 7.01 — Regulation FD Disclosure
Item 7.01 — Regulation FD Disclosure filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
the Company issued a press release in accordance with Nasdaq Listing Rule 5810(b) announcing that the Company had received the Notice
Vestand disclosed receiving a notice from Nasdaq under Listing Rule 5810(b), which governs deficiency notifications. The company issued a press release on April 29, 2026 to announce this notice. The forward-looking statements reference 'Delinquent Reports' and the need to 'regain compliance under the Nasdaq Listing Rules,' indicating the notice relates to failure to file required periodic reports on time.
Added in current filing · verify on EDGAR →
there can be no assurance that the Company will regain compliance with the Periodic Filing Requirement during any compliance period or in the future, or otherwise meet Nasdaq compliance standards
The company explicitly states it cannot guarantee it will cure the filing deficiency or meet Nasdaq's ongoing listing standards. This disclosure acknowledges material uncertainty about whether Vestand can avoid delisting, which would significantly impact stock liquidity and investor access.
Event · Item 9.01 — Financial Statements and Exhibits
Vestand Inc. filed an 8-K attaching a press release dated April 29, 2026; no material business event disclosed in the filing body.
Added in current filing · verify on EDGAR →
Press Release dated April 29, 2026
The 8-K references an attached press release dated April 29, 2026 (Exhibit 99.1). The filing body itself contains no disclosure of the press release content or the underlying corporate event. Without access to the exhibit, the materiality and nature of the announcement cannot be determined from this filing.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 2, 2026 · How we verify